The value of sequencing the entire genome, including non-coding regions, for understanding tumor proliferation mechanisms is shown by the identification of an intergenic enhancer region upstream of AR, that is amplified in 81% of the mCRPC patients and correlates to increased AR expression20,21. This evidence concerns the gene AR and neoplasm.